Stockscreener 앱 받기
1.16
3.57%
0.04
시간 외 거래:
1.17
0.01
+0.86%
전일 마감가:
$1.12
열려 있는:
$1.1004
하루 거래량:
75,010
Relative Volume:
0.58
시가총액:
$51.28M
수익:
$18.89M
순이익/손실:
$-20.44M
주가수익비율:
-1.4726
EPS:
-0.7877
순현금흐름:
$-46.69M
1주 성능:
+0.00%
1개월 성능:
+16.00%
6개월 성능:
+89.54%
1년 성능:
-29.70%
1일 변동 폭
$1.1004
$1.18
1주일 범위
$1.08
$1.25
52주 변동 폭
$0.50
$2.64
Elutia Inc Stock (ELUT) Company Profile
명칭
Elutia Inc
전화
240-247-1143
주소
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
1.16 | 49.51M | 18.89M | -20.44M | -46.69M | -0.7877 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-11-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-02 | 개시 | Cowen | Outperform |
| 2020-11-02 | 개시 | Piper Sandler | Overweight |
| 2020-11-02 | 개시 | Truist | Buy |
Elutia Inc 주식(ELUT)의 최신 뉴스
Elutia Stock Flat Ahead of Open as $1.5 Billion Decision Waits - Bez Kabli
Elutia Inc. (ELUT) Slips 3.33% as Stock Tests Key Support LevelsStop Run - thelegaladvocate.com
Elutia Inc. (ELUT) Dips 3.33% as Stock Hovers Near Critical $1.10 SupportRevenue Growth Stocks - Newser
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching - GlobeNewswire
ELUT Q1 2026 Earnings: EPS Misses Estimates as Stock Moves HigherPro Trader Picks - Newser
Elutia (ELUT) Q1 2026 Earnings Miss by Significant: Key TakeawaysEarnings Season Preview - Newser
Elutia (ELUT) Q1 2026 Results: Profit Pressure, Guidance CutPost-Earnings Reaction - Newser
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Sahm
ELUT: Antibiotic-eluting matrix targets high breast reconstruction infection rates in a $1.5B market - TradingView
Elutia (ELUT) Q1 2026 Earnings Miss: EPS $-0.17 vs $-0.15 ExpectedGuidance Upgrade Report - thelegaladvocate.com
Is Elutia (ELUT) Overvalued After Q1 2026? EPS Not Disclosed; Re - GuruFocus
Elutia (ELUT) Q1 2026 Earnings Transcript - AOL.com
Elutia (NASDAQ: ELUT) posts wider Q1 2026 loss while holding $28.5M cash - Stock Titan
About Us | Oil & Gas JournalElutia, Inc.Class A Common Stock (Nasdaq:ELUT) Stock Quote - FinancialContent
Elutia Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ELUT) 2026-05-15 - Seeking Alpha
Elutia Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Elutia to Present at the 16th Annual LD Micro Invitational on May 18th - Sahm
Elutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Ad - GuruFocus
Number of shareholders of Elutia, Inc. – NASDAQ:ELUT - TradingView
Transcript : Elutia Inc., Q1 2026 Earnings Call, May 14, 2026 - marketscreener.com
ELUT: Q1 2026 delivered revenue growth, margin gains, and strategic progress toward NXT-41x launch - TradingView
Elutia Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Elutia’s Q1 2026 earnings miss EPS, revenue exceeds forecast - Investing.com
Elutia earnings missed by $0.02, revenue topped estimates - Investing.com Canada
Elutia Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Elutia 1Q Loss $7.47M >ELUT - Moomoo
Elutia reports Q1 results, expects FDA clearance for NXT-41 By Investing.com - Investing.com South Africa
Elutia : Presentation (ELUT Earning Call 14May26 Final) - marketscreener.com
Elutia reports Q1 results, expects FDA clearance for NXT-41 - Investing.com
ELUTIA ($ELUT) Releases Q1 2026 Earnings - Quiver Quantitative
Elutia to detail tech to curb infections after breast cancer reconstruction - Stock Titan
Elutia (NASDAQ: ELUT) Q1 loss deepens while NXT-41 pipeline and margins progress - Stock Titan
Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Elutia Reports First Quarter 2026 Results and Highlights - GlobeNewswire
Elutia to Present at the 16th Annual LD Micro Invitational May 18th - TMX Newsfile
TradingKey - TradingKey
ELUTIA INC (ELUT) Eps Diluted (TTM) - Zacks Investment Research
Earnings Preview: Elutia to Report Financial Results Post-market on May 14 - Moomoo
Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - The Manila Times
ELUT Elutia delivers blowout Q4 2025 EPS results, yet shares fall 1.83% in post-earnings trading.PEG Ratio - newser.com
What factors are influencing Elutia (ELUT) stock | Q4 2025: EPS Beats ForecastsStock Market Community - newser.com
Elutia (ELUT) Stock Movers | Q4 2025: EPS Tops ViewsTurnaround Phase - Cổng thông tin điện tử tỉnh Lào Cai
ELUT (Elutia Inc.) posts a profitable Q4 2025 EPS result that far exceeds Wall Street’s consensus loss estimates. - Xã Thanh Hà
Elutia (NASDAQ: ELUT) seeks approval for larger equity plan and board slate - Stock Titan
[ARS] ELUTIA INC. SEC Filing - Stock Titan
Elutia (ELUT) Stock Volume Cluster (Smart Money Exits) 2026-04-20Correlation Analysis - Cổng thông tin điện tử tỉnh Lào Cai
ELUT (Elutia) delivers blowout Q4 2025 EPS results, with its stock price unchanged in trading today.Guidance vs Actual - Newser
Boston Scientific buys Elutia's bioenvelope business for $88 million - MSN
Elutia Inc (ELUT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.94%
자본화:
|
볼륨(24시간):